Clinical Trial Update: Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis [NA]

View source ↗

Summary

Status update on a clinical trial evaluating the NucleoCapture Device for reducing circulating cfDNA/NETs in sepsis patients; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure
• Sepsis

Snippet

Sponsor: Santersus AG | Conditions: Sepsis, Respiratory Failure | NA | Status: NOT_YET_RECRUITING